Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse - Moderna ( NASDAQ:MRNA )
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Pfizer Inc. PFE and recommended buying more of the stock. On Sept. 16, Cantor Fitzgerald analyst Louise Chen reiterated Pfizer with an Overweight rating and maintained a $45 price target.
https://www.benzinga.com/trading-ideas/long-ideas/24/09/40917190/jim-cramer-labels-moderna-a-big-disappointment-but-suggests-doubling-down-on-another-pha